Microbot Medical Inc. (MBOT), a preclinical medical device company, specializes in the design, development, and commercialization of transformational micro-robotic medical technologies. The company’s objective is to leverage its proprietary micro-robotic technologies to improve and reduce the complexity of clinical procedures.
Established in 2010 and headquartered in Hingham, Massachusetts, Microbot Medical Inc. is publicly traded on NASDAQ under the ticker symbol "MBOT". The company's innovative approach is fueled by two technology platforms – ViRob and TipCAT. The ViRob platform focuses on a miniature scale robotic technology, which can potentially navigate and penetrate tissues within the human body. The TipCAT platform, on the other hand, is a self-propelled, flexible, and semi-disposable endoscope that provides see & treat capabilities in anatomic sites that were previously inaccessible.
The company’s product line advances the field of minimally invasive surgery by providing a faster, cheaper, and less risky method due to its micro-robotic technologies. The devices it is developing, such as the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and Normal Pressure Hydrocephalus (NPH) and the Early Sepsis Detection System, hold the potential to revolutionize specific areas of medicine.
In terms of research and development, Microbot Medical Inc. consistently invests time and resources to continue the development and commercialization of its innovative products. For instance, the company's collaboration with Brigham and Women’s Hospital, a teaching affiliate of Harvard Medical School, entails the development of a robotic endoluminal platform.
However, as a preclinical company, Microbot Medical Inc. faces some challenges. Its products are still in the development stage and have not yet received regulatory approval to proceed with human trials. The company is reliant on securing the necessary funding to continue its operations and move its product candidates through the clinical development process. Despite these challenges, Microbot Medical Inc.’s commitment to transform medical treatment with innovations in the field of micro-robotics makes it a pioneering entity in the medical device industry.